Physician profile
Mary K Horner
NPI 1366803645
$1,877.57
in general payments reported to CMS, 2019-2025
20 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $828 · 2022: $294 · 2023: $303 · 2024: $305 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $448.19 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $358.80 | 2021 | |
| Lilly USA, LLC | $272.65 | 2021-2025 | Kisunla, Reyvow, Emgality |
| Amgen INC. | $157.01 | 2021-2022 | |
| Celgene Corporation | $98.00 | 2021-2022 | |
| Pfizer INC. | $74.61 | 2024 | |
| Eisai INC. | $69.11 | 2023-2024 | |
| Amneal Pharmaceuticals LLC | $58.79 | 2021-2024 | Rytary |
| Lundbeck LLC | $57.07 | 2022-2023 | Vyepti |
| Kyowa Kirin, INC. | $38.99 | 2024 | Nourianz |
| Alexion Pharmaceuticals, INC. | $36.31 | 2024 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $33.92 | 2021 | |
| Biogen, INC. | $33.87 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.60 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $25.62 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $20.95 | 2021 | |
| Genentech USA, INC. | $19.99 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.50 | 2023 | Rexulti |
| Upsher-Smith Laboratories LLC | $13.80 | 2021 | |
| Neurelis, INC. | $13.79 | 2024 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Horner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.